OpenAlex
PricingAboutJobs
Log inGet started
Work

Reduction of the Occurrence of Acute Cellular Rejection Among Renal Allograft Recipients Treated With Basiliximab, a Chimeric Anti-interleukin-2-receptor Monoclonal Antibody1,2

HTML

Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Transplantation
DOI: 10.1097/00007890-199901270-00016
Authors: Barry D. Kahan, P. R. Rajagopalan, Michael Hall
Institutions: The University of Texas Health Science Center at Houston, Medical University of South Carolina, Novartis (Switzerland), University of South Carolina, Novartis (United States)
Language: English

Topic: Renal Transplantation Outcomes and Treatments
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Keywords: basiliximab, acute cellular rejection, kidney transplant recipients, kidney transplantation, interleukin-2 receptor blockade, graft survival, cyclosporine, adverse events, renal dysfunction, serum creatinine, transplant rejection prevention, chimeric monoclonal antibody
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2123720448
FWCI: 32.7
Cites: 35
Cited by: 494
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms